.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Moodys
Fish and Richardson
McKesson
Novartis
Accenture
QuintilesIMS
Queensland Health
UBS
Harvard Business School
Citi

Generated: June 27, 2017

DrugPatentWatch Database Preview

Mercaptopurine - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for mercaptopurine and what is the scope of mercaptopurine patent protection?

Mercaptopurine
is the generic ingredient in three branded drugs marketed by Nova Labs Ltd, West-ward Pharms Int, Stason Pharms, Dr Reddys Labs Intl, and Mylan, and is included in five NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are ten drug master file entries for mercaptopurine. Seven suppliers are listed for this compound.

Summary for Generic Name: mercaptopurine

Tradenames:3
Patents:1
Applicants:5
NDAs:5
Drug Master File Entries: see list10
Suppliers / Packagers: see list7
Bulk Api Vendors: see list123
Clinical Trials: see list186
Patent Applications: see list106
Therapeutic Class:Antineoplastics
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:mercaptopurine at DailyMed

Pharmacology for Ingredient: mercaptopurine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
West-ward Pharms Int
MERCAPTOPURINE
mercaptopurine
TABLET;ORAL040528-001Feb 13, 2004ABRXNoYes► Subscribe► Subscribe
Mylan
MERCAPTOPURINE
mercaptopurine
TABLET;ORAL040594-001Jul 1, 2005ABRXNoNo► Subscribe► Subscribe
Nova Labs Ltd
PURIXAN
mercaptopurine
SUSPENSION;ORAL205919-001Apr 28, 2014RXYesYes► Subscribe► Subscribe
Dr Reddys Labs Intl
MERCAPTOPURINE
mercaptopurine
TABLET;ORAL040461-001Feb 11, 2004ABRXNoNo► Subscribe► Subscribe
Stason Pharms
PURINETHOL
mercaptopurine
TABLET;ORAL009053-002Approved Prior to Jan 1, 1982ABRXYesNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Farmers Insurance
Healthtrust
McKinsey
Moodys
Chinese Patent Office
Federal Trade Commission
Harvard Business School
Accenture
Daiichi Sankyo
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot